Company Data
Stoke Therapeutics Inc.
Ticker
STOK
Current Price
$8.33 -4.69%
Market Cap
$441.2M
Price Target
Refer to Report
Volume
1.0M
52wk Range
$5.145 - $17.58
Overview
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels.